Scienture Holdings, Inc. (Nasdaq: SCNX) announced entering into a securities purchase agreement with institutional investors.
The agreement is for purchasing 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million.
Offering Details
Offering price: $1.20 per share, Total shares: 3,225,000, Gross proceeds: $3.9 million.
Expected Closing
The offering is expected to close on August 15, 2025, subject to customary closing conditions.
Placement Agent
Maxim Group LLC is the sole placement agent for the offering.
- Scienture Holdings aims to enhance value for patients, physicians, and caregivers through specialty pharmaceutical products.
- The securities purchase agreement signifies a strategic move for future growth and market expansion.
This agreement marks a significant milestone for Scienture Holdings, positioning the company for further development and market outreach.